Ticker
CLSDCompany Name
CLEARSIDE BIOMEDICAL INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -27M | -2008.71% | $ 1.34M |
3/31/2025 | $ -30.1M | -2098.74% | $ 1.43M |
12/31/2024 | $ -34.35M | -2064.42% | $ 1.66M |
9/30/2024 | $ -31.88M | -413.83% | $ 7.7M |
6/30/2024 | $ -33.46M | -444.66% | $ 7.52M |
3/31/2024 | $ -34.97M | -413.72% | $ 8.45M |
12/31/2023 | $ -32.48M | -394.91% | $ 8.23M |
9/30/2023 | $ -37.32M | -1687.74% | $ 2.21M |
6/30/2023 | $ -35.88M | -2217.31% | $ 1.62M |
3/31/2023 | $ -34.58M | -3514.53% | $ 984K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for CLEARSIDE BIOMEDICAL INC is calculated as follows: EBIT [ $ -14.19M ] / Revenues [ $ 9.82M ]
(=) EBIT % [ -144.47% ]
Minimum
Mar 31, 2023
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |